← Back to Insights
Briefing · Enterprise Data Access

AI Made the Access Queue Louder. Approval Is Still the Work.

A verified read on the mechanisms that have moved regulated data entitlements, the clocks they changed, and why faster tooling does not make an undecided policy cheap.

Conditional sign-off verdict

Safe to accelerate one recurring regulated-data entitlement if the use is bounded, the proof is reusable, and a named owner has delegated routine cases to an executable lane. Do not sign off on broad access speed when each request still creates a novel purpose, liability, or policy decision.

The approval product

Bound the use

Name the purpose, data fields, risk tier, eligible identity, retention, and external exposure. Routine access begins with a complete request.

Reuse the proof

Carry forward approved agreements, identity evidence, control tests, enclave rules, and standard purpose language instead of rebuilding them.

Delegate the lane

Let an administrative path handle policy-aligned cases. Reserve committee judgment for precedent, exceptions, and changed risk.

Provision and expire

Automate enforcement, logging, expiry, and revocation after the decision boundary is settled. Measure decision and provisioning time separately.

Owner, briefing, proof

Owner

An accountable entitlement owner with authority to accept residual risk, delegate routine cases, and resolve exceptions.

Briefing

A one-page approval contract naming purpose, data tier, eligible roles, controls, expiry, service objective, and exception lane.

Proof

Request and decision timestamps, provisioning time, evidence-reuse rate, incidents, expired grants, exceptions, and revoke performance.

What leaders should take from it

1
Risk segmentation has the strongest measured fast path.

At UNC, 83.1% of 319 clinical-data requests entered an administrative pathway and 72.5% of those cleared within 14 days. Among the smaller committee lane, 35.2% took at least 61 days. NCATS states a usual 15-business-day request-to-workspace cycle inside a bounded national process. Both are research-governance rails, where the lawful basis was settled before the queue began; production AI is where that basis is still the open question, so borrow the design only after the legal groundwork in the approval product below.

2
Law can change the default decision, but not the delivery physics.

Open Banking imposed a duty, common standards, and a funded implementation entity. The rail still ran years late and far over its initial estimate. Regulation can move formal entitlement without making every use prompt or complete.

3
Reusable evidence lowers repeated review work.

FedRAMP and N3C show the mechanism: assess common controls or agreements once, then make a narrower residual decision for each agency or project. The public evidence supports reduced effort, but not a universal marginal-cost figure.

4
Fast enforcement is not a fast entitlement decision.

Zanzibar enforces settled policy in milliseconds. DUOS matched committee decisions for 51 automatically adjudicated genomic-data proposals, yet later adoption research still found priority and delegation concerns. Tooling executes authority that the organization has already granted.

5
Urgency without authority and capacity does not clear the queue.

Federal access mandates still missed deadlines when legal authority, technical capacity, ownership, or an executable control process remained unresolved. An executive instruction to move faster is incomplete unless it also assigns residual risk and the means to act.

Where the evidence stops

No reviewed cross-industry study compares approver scorecards, compensation, incident accountability, or promotion outcomes with entitlement speed. The evidence supports organizational decision cost and named fast-path mechanisms. It does not prove that control teams are universally rewarded for denial, that regulation always accelerates access, or that policy-as-code can replace institutional delegation.

The findings in full

9/10
The strongest measured fast path is risk segmentation, not blanket self-service.

UNC sent 265 of 319 clinical-data requests through an administrative lane. Of those, 72.5% cleared within 14 days. Only 16.9% required full committee review, and 35.2% of that smaller group took at least 61 days. The mechanism combined one intake, a structured request, trained brokers, alignment to existing approval, and escalation for higher-risk or controversial uses. NCATS uses the same control family at national scale and states that its bounded N3C process usually takes 15 business days from request to workspace.

8/10
A legal duty can move access when it changes the cost of saying no.

The UK Open Banking order required nine large banks to fund a common implementation entity, use shared standards, and enable customer-authorized access. Six had completed the roadmap by January 2023, while three had not. A remedy expected to finish in January 2018 remained incomplete more than five years later and cost more than £150 million against an initial estimate below £20 million. Regulation changed the formal entitlement, but it did not make implementation prompt, cheap, or complete.

8/10
Reusable evidence and umbrella agreements reduce duplicated review.

FedRAMP standardized security assessment, authorization, and monitoring so agencies could reuse evidence. Twenty-one surveyed agencies said leveraging Joint Authorization Board authorizations reduced time and effort, although GAO did not measure marginal approval cost. N3C signs one institutional agreement for all users, then makes a narrower project decision inside a controlled enclave. Both mechanisms centralize proof while preserving a named residual authorizer.

8/10
Tooling can make enforcement instant before it makes the approval decision cheap.

Zanzibar showed authorization enforcement below 10 milliseconds p95 at global scale. DUOS encoded 118 of 123 genomic data-use limits and all 52 proposals, and 51 received a head-to-head comparison against committee review with full concordance. Later committee research still found low prioritization, concern about over-automation, and uncertainty about efficiency. The technology can execute a decision boundary that the organization has delegated; it cannot create that delegation by itself.

7/10
Executive urgency is insufficient when authority, capacity, and the operating rail remain unchanged.

The CASES Act required electronic access and consent forms, yet only one of 17 reviewed agencies had fully implemented the requirement by September 2022. In disaster lending, SBA and IRS wanted near-real-time data sharing, but SBA lacked statutory authority for direct consent-free receipt. Mandates may not produce timely access when legal authority, technical capacity, accountable ownership, or an executable control process remains unresolved.

First moves before buying more tooling

01
Split the clock.

Report request-to-decision and decision-to-provision separately, including median and 90th percentile by data class, owner, exception type, and review lane.

02
Build one pre-approved entitlement product.

Settle the legal basis first, as preconditions rather than fields: lawful basis for the intended use, purpose-limitation test, minimum-necessary determination, any cross-border transfer mechanism, named processors and their contract terms, and the vendor's training-use and retention position. Then name the operating attributes: purpose, fields, risk tier, eligible roles, controls, retention, expiry, evidence owner, and exception lane, with an explicit deny path alongside the approve path.

03
Make low-risk review administrative.

Use completeness checks and existing policy alignment for routine cases. Escalate changed purpose, sensitivity, sharing, population, or external exposure.

04
Reuse the authorization artifact.

Carry forward umbrella agreements, approved data tiers, enclave controls, identity proof, automatic expiry, and standard evidence packages.

05
Put residual risk and capacity inside the mandate.

Name the accountable executive, control owner, service objective, incident threshold, exception budget, and authority to change policy.

06
Test the incentive hypothesis.

Review safe time-to-entitlement, request quality, expiry hygiene, and incidents per 1,000 grants together, as measures of the system. Look for speed without a worse control outcome. Keep these off the personal scorecards of independent control roles: their objectives and compensation are governed by rules a transformation office does not set, so that change belongs to a board committee. Measure the queue, not the officer.

Where to start

Start with one recurring AI workflow and one data class. Build the approval product, measure it for a quarter, and widen only if access gets faster without worse control outcomes. If the use cannot be bounded or the residual-risk owner lacks authority, keep it in the exception lane.

Claim ledger

16/16
Checked
citations traced to primary sources on August 6, 2026
0
Fabricated
no invented source or unsupported citation survived verification
7
Corrected
dates, figures, attribution, and claim scope narrowed after source review
1
Demoted
indirect incentive evidence held outside the core verdict
ConfirmedWalters et al., UNC: 319 clinical-data requests; 83.1% entered an administrative lane, 72.5% of those cleared within 14 days, and 35.2% of committee cases took at least 61 days. One mature health-research system.academic.oup.com
ConfirmedNCATS N3C: official guidance states a usual 15-business-day request-to-workspace cycle, one institutional agreement, project-specific review, risk tiers, training, and a secure enclave. Service expectation, not an audited outcome sample.ncats.nih.gov
CorrectedLawson et al.: self-selected survey with 35 respondents, not 35 distinct committees. Eight respondents reported no interest in automated approval; some printed percentages do not reconcile cleanly to the sample.nih.gov
CorrectedRamos et al., GAIN: median receipt-to-approval fell from 14 days in 2007 to 8 days in 2011. Weekly review began in 2009, but the descriptive study does not isolate causality.nih.gov
CorrectedCabili et al., DUOS: encoded 118 of 123 use limitations and all 52 proposals; 51 received a head-to-head comparison against committee review with full concordance. No entitlement-time outcome. Corrected 2026-08-25: an earlier version said the fifty-second proposal went to manual review, a disposition no cited source states.doi.org
ConfirmedRahimzadeh et al.: 13 interviews covered 17 committee members and found support for bounded pilots alongside mission-fit, priority, and over-automation concerns.nih.gov
CorrectedGAO on SBA and IRS: missing statutory authority prevents direct consent-free sharing. Manual consent verification is the workaround, not the legal cause.gao.gov
ConfirmedCMA Open Banking order: nine providers had to fund a common implementation entity and support customer-consented access through shared standards; six had completed the roadmap by January 2023.gov.uk
ConfirmedCMA lessons review: implementation expected to finish in January 2018 remained incomplete more than five years later and exceeded £150 million against an initial estimate below £20 million.gov.uk
CorrectedONC hospital survey: hospital-reported possible information blocking by any actor fell from 42% in 2021 to 19% in 2025. The first wave was already post-applicability, so it is not a pre-rule baseline.healthit.gov
ConfirmedONC HIO survey: 71% of 77 responding organizations still reported some possible information blocking in 2025. Perception evidence, not measured entitlement time.healthit.gov
CorrectedGAO on the CASES Act: only one of 17 reviewed agencies had fully implemented required digital access and consent forms by September 2022. The purposive sample is not generalizable.gao.gov
CorrectedGAO on FedRAMP: authorizations rose 137% from 2017 to 2019, while 15 of 24 agencies did not always use the program. Agencies reported lower time and effort; GAO did not measure marginal approval cost.gao.gov
ConfirmedPang et al., Zanzibar: authorization below 10 milliseconds p95 at global scale. This is enforcement latency, not institutional time-to-entitlement.usenix.org
ConfirmedHIPAA security rule: requires named security responsibility, access procedures, activity review, incident response, and sanctions. This establishes accountability, not career incentives.ecfr.gov
DemotedTetlock and Boettger: a simulated pharmaceutical decision supports status quo bias under accountability when change creates victims. It is indirect evidence for enterprise data entitlement.doi.org
Contested signal: held out of the verdict

Approver accountability may overweight visible downside, but no cited study compares approver scorecards, compensation, incident accountability, or promotion outcomes with entitlement speed. The direct evidence points first to request completeness, policy interpretation, identity checks, committee capacity, legal authority, and delegated decision rights.

What would change this conclusion

Related work

Verified research · 16 citations checked · 0 fabricated · 7 corrected · 1 demoted